Progress in metabolomics research of diabetes / 药学学报
Xin LI; Hai-yan MA; Lu-pan LI; Shan-shan SUN; Li-jun ZHU; Yu-feng LIU.
Acta Pharmaceutica Sinica
; (12): 828-837, 2019.
Artículo
en Zh
| WPRIM | ID: wpr-780192
Diabetes is a metabolic disease with an extremely high incidence in China. In parallel with an increased incidence yearly, the population of diabetes is showing a trend towards younger age. Therefore, it is urgent to carry out research on diabetes in order to develop strategy for prevention. In recent years, metabolomics has made significant progress in the study of biomarkers, pathogenesis, early diagnosis and prognosis, and evaluation of drug efficacy in diabetes. However, limited by metabolomics technology and the complexity of diabetes research, metabolomics in the diabetes research remains challenging. We summarize the progress and prospect the future development of metabolomics in the diabetes research.
Biblioteca responsable:
WPRO
Texto completo
Documentos relacionados